- Home
- NVCT vs SSSS Comparison
NVCT vs SSSS Comparison
Compare NVCT & SSSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NVCT
- SSSS
- Stock Information
- Founded
- NVCT 2020
- SSSS 2010
- Country
- NVCT United States
- SSSS United States
- Employees
- NVCT N/A
- SSSS N/A
- Industry
- NVCT Medicinal Chemicals and Botanical Products
- SSSS Finance: Consumer Services
- Sector
- NVCT Health Care
- SSSS Finance
- Exchange
- NVCT Nasdaq
- SSSS Nasdaq
- Market Cap
- NVCT 152.3M
- SSSS 138.2M
- IPO Year
- NVCT 2022
- SSSS N/A
- Fundamental
- Price
- NVCT $6.43
- SSSS $8.45
- Analyst Decision
- NVCT Strong Buy
- SSSS Strong Buy
- Analyst Count
- NVCT 3
- SSSS 4
- Target Price
- NVCT $15.33
- SSSS $9.50
- AVG Volume (30 Days)
- NVCT 234.7K
- SSSS 167.3K
- Earning Date
- NVCT 08-05-2025
- SSSS 08-06-2025
- Dividend Yield
- NVCT N/A
- SSSS 11.77%
- EPS Growth
- NVCT N/A
- SSSS N/A
- EPS
- NVCT N/A
- SSSS 2.22
- Revenue
- NVCT N/A
- SSSS $2,784,381.00
- Revenue This Year
- NVCT N/A
- SSSS $6.95
- Revenue Next Year
- NVCT N/A
- SSSS N/A
- P/E Ratio
- NVCT N/A
- SSSS $3.83
- Revenue Growth
- NVCT N/A
- SSSS N/A
- 52 Week Low
- NVCT $4.44
- SSSS $3.71
- 52 Week High
- NVCT $11.80
- SSSS $9.12
- Technical
- Relative Strength Index (RSI)
- NVCT 39.18
- SSSS 52.04
- Support Level
- NVCT $6.18
- SSSS $8.40
- Resistance Level
- NVCT $6.99
- SSSS $8.67
- Average True Range (ATR)
- NVCT 0.50
- SSSS 0.30
- MACD
- NVCT -0.03
- SSSS -0.04
- Stochastic Oscillator
- NVCT 31.18
- SSSS 53.12
About NVCT Nuvectis Pharma Inc.
Nuvectis Pharma Inc is a biopharmaceutical company. The company is engaged in the development of innovative precision medicines for the treatment of serious conditions of unmet medical needs in oncology. It operates with one segment, focused on the development of novel targeted small molecule therapeutics for the treatment of cancer in genetically defined patient populations. Its pipeline products include NXP800, NXP900.
About SSSS SuRo Capital Corp.
SuRo Capital Corp is a non-diversified closed-end management investment company. The company's investment objective is to maximize its portfolio's total return, principally by seeking capital gains on its equity and equity-related investments.